Development Level

Tbio 4 | 10,625
Tchem 3 | 1,890

IMPC Term

immune system phenotype 1 | 17

Disease

psoriasis 6 | 6,685
Cancer 5 | 2,346
Schizophrenia 5 | 501
osteosarcoma 5 | 7,933
Alzheimer's disease 4 | 644
Hypertension 4 | 287
Obesity 4 | 616
diabetes mellitus 4 | 1,663
glioblastoma 4 | 5,572
ovarian cancer 4 | 8,484
Amnestic disorder 3 | 37
Anxiety Disorders 3 | 37
Anxiety disorder 3 | 22
Arthritis 3 | 248
Autistic Disorder 3 | 320
Cerebrovascular disease 3 | 231
Cocaine-Related Disorders 3 | 88
Epilepsy 3 | 346
Hyperactive behavior 3 | 31
Irritable bowel syndrome 3 | 59
Migraine 3 | 79
Morphine dependence 3 | 19
Pain agnosia 3 | 99
Parkinson's disease 3 | 364
Toxic encephalopathy 3 | 131
atypical teratoid / rhabdoid tumor 3 | 4,369
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
pediatric high grade glioma 3 | 2,712
primitive neuroectodermal tumor 3 | 3,031
Alcohol dependence 2 | 107
Asthma 2 | 349
Dementia 2 | 129
Diarrhea 2 | 155
Down syndrome 2 | 548
Edema 2 | 38
Flushing 2 | 5
Huntington's disease 2 | 72
Hypertensive disease 2 | 193
Hypoglycemia 2 | 81
Hypotension 2 | 53
Inflammatory bowel disease 2 | 142
Major Depressive Disorder 2 | 106
Narcolepsy 2 | 58
Pain 2 | 70
Rhinitis 2 | 46
Seizures 2 | 95
Substance Withdrawal Syndrome 2 | 52
Waldenstrons macroglobulinemia 2 | 765
Withdrawal disorder 2 | 19
astrocytoma 2 | 1,493
chronic kidney disease 2 | 90
colon cancer 2 | 1,475
ependymoma 2 | 2,514
group 4 medulloblastoma 2 | 1,875
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
lung carcinoma 2 | 2,844
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
pilocytic astrocytoma 2 | 3,086
posterior fossa group A ependymoma 2 | 1,511
ulcerative colitis 2 | 2,087
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Acute Lung Injury 1 | 18
Amenorrhea 1 | 60
Anorexia nervosa 1 | 59
Asperger syndrome 1 | 35
Bilirubin metabolic disorder 1 | 39
Bronchial Hyperreactivity 1 | 13
Bulimia nervosa 1 | 15
Cholera 1 | 33
Complex regional pain syndrome 1 | 12
Constipation 1 | 43
Eating disorder 1 | 24
Ectopic pregnancy 1 | 16
Epicondylitis 1 | 19
Fibromyalgia 1 | 22
Fibrous dysplasia 1 | 15
Gastrointestinal system disease 1 | 50
Gaucher disease type 3 1 | 76
Hepatic encephalopathy 1 | 25
Hepatitis C 1 | 90
Hypokalemia 1 | 40
Impotence 1 | 45
Infarction, Middle Cerebral Artery 1 | 25
Ischemia 1 | 27
Mammary Neoplasms, Experimental 1 | 150
Mastitis 1 | 48
Myocardial Infarction 1 | 126
Myopia 1 | 99
Neonatal jaundice 1 | 15
Oligohydramnios 1 | 18
Osteopetrosis 1 | 40
Placenta praevia 1 | 9
Placental insufficiency 1 | 13
Prader-Willi syndrome 1 | 45
Sudden infant death syndrome 1 | 33
Weight Gain 1 | 87
Weight decreased 1 | 18
fascioscapulohumeral muscular dystrophy 1 | 100

Tissue

Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Nervous System 7 | 18,561
Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Respiratory system 6 | 17,484
Urinary Tract 6 | 18,444
Skin and soft tissues 5 | 18,115

Target Family

Non-IDG 4 | 11,971
Transcription Factor 2 | 1,400
GPCR 1 | 406

Grant Application

1Z01NS002723-21 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Proto-oncogene c-Fos FOS Tchem Transcription Factor -4.11560 13094.7 961
VIP peptides VIP Tbio Non-IDG -3.54298 4022.9 276
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
Oxytocin-neurophysin 1 OXT Tbio Non-IDG -4.16090 14677.4 133
Vasoactive intestinal polypeptide receptor 2 VIPR2 Tchem GPCR -2.17906 136.5 228
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Cyclic AMP-responsive element-binding protein 1 CREB1 Tbio Transcription Factor -3.58304 3764.1 1385